SEI INVESTMENTS CO

Position in IMCR — Immunocore Holdings plc

CIK 350894 OAKS, PA

Position in IMCR

as of Mar 31, 2026 · filed May 13, 2026 Compact

Position Value

$1,846,988

+$99,791 QoQ

Shares Held

61,260

+21.7% QoQ

Ownership

0.120%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

SEI INVESTMENTS CO holds $1,293,253,921 across 195 Biotechnology names. IMCR ranks #63 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	1,395,794	$228,240,234
2	ARGX	Argenx SE	286,966	$209,556,920
3	ASND	Ascendis Pharma A/S	351,146	$80,317,623
4	EXEL	Exelixis, Inc.	1,629,670	$69,896,545
5	INCY	Incyte Corp	714,558	$67,254,197
6	VRTX	Vertex Pharmaceuticals Inc / Ma	133,226	$59,490,737
7	REGN	Regeneron Pharmaceuticals, Inc.	75,000	$57,947,999
8	ALNY	Alnylam Pharmaceuticals, Inc.	100,315	$33,191,223

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,846,988	61,260	+21.7%	Shares	Sole	2026-05-13
2025-12-31	$1,747,197	50,337	+43.9%	Shares	Sole	2026-02-13
2025-09-30	$1,271,004	34,985	+11.7%	Shares	Sole	2025-11-13
2025-06-30	$983,260	31,334	+191.9%	Shares	Sole	2025-08-14
2025-03-31	$318,537	10,736	+84.9%	Shares	Sole	2025-05-14
2024-03-31	$377,455	5,807	+1.9%	Shares	Sole	2024-05-07
2023-12-31	$389,424	5,700	-79.8%	Shares	Sole	2024-02-14
2023-09-30	$1,463,943	28,207	+2.2%	Shares	Sole	2023-11-14
2023-06-30	$1,654,116	27,587	-34.1%	Shares	Sole	2023-08-11
2023-03-31	$2,069,261	41,854	+235.8%	Shares	Sole	2023-05-12
2022-12-31	$711,320	12,464	-56.6%	Shares	Sole	2023-02-10
2022-09-30	$1,348,257	28,723	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.